These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38830925)

  • 1. Basic host response parameters to classify mortality risk in COVID-19 and community-acquired pneumonia.
    Menéndez R; Méndez R; González-Jiménez P; Latorre A; Reyes S; Zalacain R; Ruiz LA; Serrano L; España PP; Uranga A; Cillóniz C; Gaetano-Gil A; Fernández-Félix BM; Pérez-de-Llano L; Golpe R; Torres A
    Sci Rep; 2024 Jun; 14(1):12726. PubMed ID: 38830925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality prediction to hospitalized patients with influenza pneumonia: PO
    Shi SJ; Li H; Liu M; Liu YM; Zhou F; Liu B; Qu JX; Cao B
    Clin Respir J; 2017 May; 11(3):352-360. PubMed ID: 26148709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community-acquired pneumonia severity assessment tools in patients hospitalized with COVID-19: a validation and clinical applicability study.
    Lazar Neto F; Marino LO; Torres A; Cilloniz C; Meirelles Marchini JF; Garcia de Alencar JC; Palomeque A; Albacar N; Brandão Neto RA; Souza HP; Ranzani OT; ; ; ;
    Clin Microbiol Infect; 2021 Jul; 27(7):1037.e1-1037.e8. PubMed ID: 33813111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 Is Distinct From SARS-CoV-2-Negative Community-Acquired Pneumonia.
    Zhou Y; Guo S; He Y; Zuo Q; Liu D; Xiao M; Fan J; Li X
    Front Cell Infect Microbiol; 2020; 10():322. PubMed ID: 32612961
    [No Abstract]   [Full Text] [Related]  

  • 5. [Severity of community-acquired pneumonia due to coronavirus SARS-CoV-2 in immunocompetent hospitalized adult patients].
    Peñafiel FS; Tapia AP; Nesvadba DF; Oksenberg KF; Sánchez AR; Meza JC; Rossel GS; Rodríguez IL
    Rev Med Chil; 2023 Sep; 151(9):1207-1220. PubMed ID: 39093158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and significance of various scores for pneumonia severity in the management of patients with community-acquired pneumonia in China.
    Yang Y; Xu F; Shi LY; Diao R; Cheng YS; Chen XY; Jing JY; Wang XD; Shen HH
    Chin Med J (Engl); 2012 Feb; 125(4):639-45. PubMed ID: 22490488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum High-Sensitivity C Reactive Protein Improves Sensitivity of CURB-65 in Predicting ICU Admission and Mortality in Community-Acquired Pneumonia Patients.
    Ge YL; Liu CH; Xu J; Cui ZY; Guo WC; Li HL; Fu AS; Wang HY; Zhang HF; Zhu XY
    Clin Lab; 2018 Oct; 64(10):1749-1754. PubMed ID: 30336524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse outcomes in patients hospitalized with pneumonia at age 60 or more: A prospective multi-centric hospital-based study in India.
    Kanungo S; Bhattacharjee U; Prabhakaran AO; Kumar R; Rajkumar P; Bhardwaj SD; Chakrabarti AK; Kumar C P G; Potdar V; Manna B; Amarchand R; Choudekar A; Gopal G; Sarda K; Lafond KE; Azziz-Baumgartner E; Saha S; Dar L; Krishnan A
    PLoS One; 2024; 19(5):e0297452. PubMed ID: 38696397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procalcitonin and C-reactive protein perform better than the neutrophil/lymphocyte count ratio in evaluating hospital acquired pneumonia.
    Zheng N; Zhu D; Han Y
    BMC Pulm Med; 2020 Jun; 20(1):166. PubMed ID: 32527243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes in patients with COPD hospitalized with SARS-CoV-2 versus non- SARS-CoV-2 community-acquired pneumonia.
    Sheikh D; Tripathi N; Chandler TR; Furmanek S; Bordon J; Ramirez JA; Cavallazzi R
    Respir Med; 2022 Jan; 191():106714. PubMed ID: 34915396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of outcomes and characteristics of patients admitted to the ICU with COVID-19 and other community-acquired pneumonia based on propensity score matching.
    Zhao H; Yan X; Guo Z; Li K; Wang Z; Wang J; Lv D; Zhu J; Chen Y
    BMC Infect Dis; 2024 Apr; 24(1):419. PubMed ID: 38644489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of clinical characteristics between coronavirus disease 2019 pneumonia and community-acquired pneumonia.
    Tian J; Xu Q; Liu S; Mao L; Wang M; Hou X
    Curr Med Res Opin; 2020 Nov; 36(11):1747-1752. PubMed ID: 32986475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive values of semi-quantitative procalcitonin test and common biomarkers for the clinical outcomes of community-acquired pneumonia.
    Ugajin M; Yamaki K; Hirasawa N; Yagi T
    Respir Care; 2014 Apr; 59(4):564-73. PubMed ID: 24170911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in hospitalized community-acquired pneumonia: a retrospective study of a prospective observational cohort.
    Ito A; Ishida T; Tokumasu H; Washio Y; Yamazaki A; Ito Y; Tachibana H
    BMC Pulm Med; 2017 May; 17(1):78. PubMed ID: 28464807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunocompetent adults hospitalized for a community-acquired pneumonia: Serum C-reactive protein as a prognostic marker].
    Saldías-Peñafiel F; Salinas-Rossel G; Farcas-Oksenberg K; Reyes-Sánchez A; Díaz-Patiño O
    Rev Med Chil; 2019 Aug; 147(8):983-992. PubMed ID: 31859962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent temporal trends, characteristics and outcomes of patients with non-COVID-19 community-acquired pneumonia at two tertiary hospitals in Australia: an observational study.
    Sharma Y; Mangoni AA; Shahi R; Horwood C; Thompson C
    Intern Med J; 2024 Oct; 54(10):1686-1693. PubMed ID: 39016078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community-acquired pneumonia and survival of critically ill acute exacerbation of COPD patients in respiratory intensive care units.
    Lu Z; Cheng Y; Tu X; Chen L; Chen H; Yang J; Wang J; Zhang L
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1867-72. PubMed ID: 27563239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive protein, severity of pneumonia and mortality in elderly, hospitalised patients with community-acquired pneumonia.
    Thiem U; Niklaus D; Sehlhoff B; Stückle C; Heppner HJ; Endres HG; Pientka L
    Age Ageing; 2009 Nov; 38(6):693-7. PubMed ID: 19729453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of inflammatory markers with frailty and in-hospital mortality in older COVID-19 patients.
    Tran Van Hoi E; Appelman B; Mooijaart S; Dalm VASH; Polinder Bos HA; van Heemst D; van Raaij BFM; Noordam R; Kuranova A; Hoogerwerf JJ; Peeters G; Smorenberg A; ; ; ;
    Exp Gerontol; 2024 Oct; 195():112534. PubMed ID: 39098360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory biomarkers and prediction for intensive care unit admission in severe community-acquired pneumonia.
    Ramírez P; Ferrer M; Martí V; Reyes S; Martínez R; Menéndez R; Ewig S; Torres A
    Crit Care Med; 2011 Oct; 39(10):2211-7. PubMed ID: 21705887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.